These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20950431)

  • 1. Butyrate suppresses expression of neuropilin I in colorectal cell lines through inhibition of Sp1 transactivation.
    Yu DC; Waby JS; Chirakkal H; Staton CA; Corfe BM
    Mol Cancer; 2010 Oct; 9():276. PubMed ID: 20950431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells.
    Kim YH; Park JW; Lee JY; Kwon TK
    Carcinogenesis; 2004 Oct; 25(10):1813-20. PubMed ID: 15142888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sp1 acetylation is associated with loss of DNA binding at promoters associated with cell cycle arrest and cell death in a colon cell line.
    Waby JS; Chirakkal H; Yu C; Griffiths GJ; Benson RS; Bingle CD; Corfe BM
    Mol Cancer; 2010 Oct; 9():275. PubMed ID: 20950428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction.
    Wilson AJ; Chueh AC; Tögel L; Corner GA; Ahmed N; Goel S; Byun DS; Nasser S; Houston MA; Jhawer M; Smartt HJ; Murray LB; Nicholas C; Heerdt BG; Arango D; Augenlicht LH; Mariadason JM
    Cancer Res; 2010 Jan; 70(2):609-20. PubMed ID: 20068171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic control of HNF-4α in colon carcinoma cells affects MUC4 expression and malignancy.
    Algamas-Dimantov A; Yehuda-Shnaidman E; Peri I; Schwartz B
    Cell Oncol (Dordr); 2013 Apr; 36(2):155-67. PubMed ID: 23307400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Krüppel-like factor 4 is transactivated by butyrate in colon cancer cells.
    Chen ZY; Rex S; Tseng CC
    J Nutr; 2004 Apr; 134(4):792-8. PubMed ID: 15051827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner.
    Shin J; Carr A; Corner GA; Tögel L; Dávalos-Salas M; Tran H; Chueh AC; Al-Obaidi S; Chionh F; Ahmed N; Buchanan DD; Young JP; Malo MS; Hodin RA; Arango D; Sieber OM; Augenlicht LH; Dhillon AS; Weber TK; Mariadason JM
    J Biol Chem; 2014 Sep; 289(36):25306-16. PubMed ID: 25037223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.
    Camarero N; Nadal A; Barrero MJ; Haro D; Marrero PF
    Nucleic Acids Res; 2003 Mar; 31(6):1693-703. PubMed ID: 12626711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitors upregulate MMP11 gene expression through Sp1/Smad complexes in human colon adenocarcinoma cells.
    Barrasa JI; Olmo N; Santiago-Gómez A; Lecona E; Anglard P; Turnay J; Lizarbe MA
    Biochim Biophys Acta; 2012 Feb; 1823(2):570-81. PubMed ID: 22227581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of BAK by butyrate in the colon is associated with increased Sp3 binding.
    Chirakkal H; Leech SH; Brookes KE; Prais AL; Waby JS; Corfe BM
    Oncogene; 2006 Nov; 25(54):7192-200. PubMed ID: 16732318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells.
    Hu S; Liu L; Chang EB; Wang JY; Raufman JP
    Mol Cancer; 2015 Oct; 14():180. PubMed ID: 26463716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the gamma-glutamyltransferase promoter 2 in the rat colon carcinoma cell line CC531 by histone deacetylase inhibitors is mediated through the Sp1 binding motif.
    Mikkelsen IM; Huseby NE; Visvikis A; Moens U
    Biochem Pharmacol; 2002 Jul; 64(2):307-15. PubMed ID: 12123752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No functional and transductional significance of specific neuropilin 1 siRNA inhibition in colon carcinoma cell lines lacking VEGF receptor 2.
    Quante M; Raskopf E; Stahl S; Vogt A; Sauerbruch T; Schmitz V
    Oncol Rep; 2009 May; 21(5):1161-8. PubMed ID: 19360289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-II renders LIM 2405 human colon cancer cells resistant to butyrate-induced apoptosis: a potential mechanism for colon cancer cell survival in vivo.
    Leng SL; Leeding KS; Gibson PR; Bach LA
    Carcinogenesis; 2001 Oct; 22(10):1625-31. PubMed ID: 11577001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins.
    Abdelrahim M; Safe S
    Mol Pharmacol; 2005 Aug; 68(2):317-29. PubMed ID: 15883203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Butyrate-induced phosphatase regulates VEGF and angiogenesis via Sp1.
    Prasanna Kumar S; Thippeswamy G; Sheela ML; Prabhakar BT; Salimath BP
    Arch Biochem Biophys; 2008 Oct; 478(1):85-95. PubMed ID: 18655767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of the intestinal Cdx2 homeobox gene by butyrate in colon cancer cells.
    Domon-Dell C; Wang Q; Kim S; Kedinger M; Evers BM; Freund JN
    Gut; 2002 Apr; 50(4):525-9. PubMed ID: 11889074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-chain fatty acid level and field cancerization show opposing associations with enteroendocrine cell number and neuropilin expression in patients with colorectal adenoma.
    Yu DC; Bury JP; Tiernan J; Waby JS; Staton CA; Corfe BM
    Mol Cancer; 2011 Mar; 10():27. PubMed ID: 21401950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory activity of ranibizumab, sorafenib, and pazopanib on light-induced overexpression of platelet-derived growth factor and vascular endothelial growth factor A and the vascular endothelial growth factor A receptors 1 and 2 and neuropilin 1 and 2.
    Kernt M; Thiele S; Neubauer AS; Koenig S; Hirneiss C; Haritoglou C; Ulbig MW; Kampik A
    Retina; 2012 Sep; 32(8):1652-63. PubMed ID: 22466477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer.
    Mariadason JM; Corner GA; Augenlicht LH
    Cancer Res; 2000 Aug; 60(16):4561-72. PubMed ID: 10969808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.